CSTM CONSTELLIUM SE Insider Trading

Director Soultz Bradley Lee buys 2,500 shares of CSTM at $33.84; stock now at $32.61, down 6.7% from 52-week high.

Soultz Bradley Lee purchased 2,500 shares at $33.84, building an initial position in CONSTELLIUM SE. The stock currently trades at $32.61, representing a modest paper loss from the transaction price. The company's fundamentals remain solid—revenue of $2,461,000,000 with annual growth of +15.2%, profitability of $199,000,000, and an attractive P/E of 10.22—providing a reasonable valuation backdrop for the transaction. However, Lee's cross-ticker track record reveals 11 prior open-market buys with an average 90-day return of -7.1% and a 22.22% win rate, suggesting limited predictive power in this transaction's favor; this transaction occurs against that historical pattern of underperformance, rather than signaling conviction-driven positioning.

CFO Guo Jack Q. sells ~$822K of CSTM shares as stock reaches 52-week highs; prior timing unclear.

CFO Guo Jack Q. sold a meaningful stake while the stock trades at its 52-week highs and has rallied sharply over recent months, a pattern that typically suggests executives are taking profits rather than betting on further upside. The company itself remains financially healthy—profitable with solid revenue growth—so this sale isn't a warning flag about fundamentals. However, this is only Guo's second recorded trade in this stock; the timing of his prior sale in early March makes it too recent to evaluate whether he was right to exit that position, leaving his track record on this specific company essentially unproven. The tension here is straightforward: an executive selling at elevated prices looks prudent, but without evidence that his prior timing decisions were sound, it's difficult to weight how much conviction to place in this particular exit.

Constellium President of A&T sells ~26% of holdings for $1.6M after strong 30-day rally

Philippe Hoffmann, President of Aerospace & Transportation at Constellium, liquidated a quarter of his shareholding after the stock rallied sharply over the prior month. The sale timing is notable: the company is profitable with solid fundamentals, yet Hoffmann chose to exit a meaningful portion of his equity stake near recent highs rather than accumulate. While this alone doesn't signal distress—portfolio rebalancing and diversification are routine for officers—the decision to sell after such a pronounced rally, when the stock had recovered from much lower levels, suggests either opportunistic profit-taking or reduced conviction at current valuations. As a President-level operational executive, Hoffmann has direct visibility into near-term conditions in a cyclical aerospace segment, making his exit timing worth monitoring alongside upcoming earnings or industry trends.

SVP & CHRO Jurkovic sells ~49K shares (22% of holdings) for $1.56M as CSTM rallies off lows.

Philip Ryan Jurkovic, the Senior Vice President and Chief Human Resources Officer, sold nearly 49,000 shares on a single date in May for approximately $1.56 million—representing about a fifth of his holdings. This is his second open-market sale in the past three years, following prior equity dispositions. The sale occurred as the stock has rallied substantially from its 52-week lows but still trades modestly below its 52-week high, suggesting the executive chose to liquidate a meaningful portion of his position near a relatively elevated price point. Constellium remains a growing, profitable company with expanding quarterly revenue, providing no obvious distress signal from fundamentals. However, the size of this single sale and Jurkovic's repetition of the selling pattern—coupled with the stock's recent sharp recovery—marks this as a material reduction in his direct equity stake at a time when the company's operational health appears intact.

CSTM director Deslarzes purchases $41,247 worth of shares in open-market transaction

Director Jean-Christophe Deslarzes bought shares at a price near the company's current trading level, adding to his holdings at a moment when the stock has recovered sharply over recent months from much lower levels. Constellium is a profitable company with solid fundamentals—growing revenue and positive earnings—trading at a reasonable valuation multiple. This purchase by a sitting director signals conviction in the company's near-term direction, particularly notable because it comes after the stock has already staged a significant recovery, suggesting Deslarzes sees further upside rather than attempting to catch a bottom. The modest size of the purchase (a small fraction of his holdings) is typical for routine board-member activity, but the timing during a strong uptrend rather than a pullback adds credibility to the signal.